Oncotrace

Oncotrace is used to identify a primary tumor in a patient and to provide guidance about disease progression and future prognosis.

During the test, a sample of blood is analyzed to identify the presence and concentration of circulating tumor cells (CTCs) and how aggressive these cells are through the study of the Cancer Stem Cell (CSC) markers. This test provides information about the presence of CTCs, their concentration, and their specific type (immunophenotype).

By studying cancer behavior, doctors and patients can monitor the status of tumor markers responsible for migration, proliferation, resistance, and metastasis.

How does Oncotrace work?

• A blood sample is taken to examine the presence and immunophenotype of Circulating Tumor Cells.
• Although the enumeration of CTCs is really important, their immunophenotype analysis provides really useful information, as well.
• This is called immunophenotyping. This analysis unravels vital information on the cancer’s nature, probability of metastatic spread, and likelihood of being chemo resistant.

How does Oncotrace help?

• Follow-up tool to monitor the cancer disease burden.
• Assessment of cancer treatment response.
• Early warning test for relapse and recurrence.
• Cancer Stem Cell (CSC) markers study help us understand the tumor behavior.